NEWS FROM USA
NDA Approvals
|
Approval Date |
Drug |
NDA Sponsor |
Brand Name |
Prescribing information |
|
03 Dec 2018 |
Dexamethasone Ophthalmic Insert |
Ocular Therapeutix |
Dextenza |
ANDA Approvals
|
Approval Date |
Drug Product |
ANDA Sponsor |
Corresponding RLD |
Number Of Other Approved Generics |
|
03 Dec 2018 |
Sun Pharma |
Ganirelix Acetate (Organon) |
None |
|
|
01 Dec 2018 |
Zydus |
AUBAGIO (SANOFI) |
Six |
|
|
28 Nov 2018 |
Mylan |
PREVACID (Takeda) |
Two (Teva, Zydus) |
|
|
28 Nov 2018 |
Aurobindo |
None |
Eight |
|
|
29 Nov 2018 |
Wilshire |
Renvela (Sanofi) |
Six |
|
|
29 Nov 2018 |
Dexmedetomidine Hydrochloride Injection (4 mcg base/ml) |
Fresenius |
Precedex (Hospira) |
One (Baxter) |
|
29 Nov 2018 |
Par Pharma |
Mitigare (Hikma ) |
None |
|
|
29 Nov 2018 |
Encube |
Lidex (Cnty Line ) |
Eight |
NEW GENERICS LAUNCHES IN US
|
DRUG |
COMPANY |
Corresponding RLD |
Annual sales quoted in press release as per IQVIA |
Press Release |
|
Nystatin and Triamcinolone Acetonide Cream |
Lupin |
Nystatin and Triamcinolone Acetonide Cream (Taro Pharma) |
$54.3 Million |
OTHER NEWS FROM EUROPE
Biosimilar Pegfilgrastim Co-Developed by Biocon Receives Approval in EU
Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com
No comments:
Post a Comment